Sanofi-aventis introduces Sculptra in Kuwait
Sanofi-aventis pharmaceuticals have launched its highly anticipated anti-ageing drug, Sculptra in Kuwait following its approval from the Kuwait Ministry of Health earlier this year. Sculptra is an injectable treatment that consists of poly-L-lactic acid sterile suspension that is biocompatible and biodegradable making it easy for the body to absorb. Sculptra also stimulates the natural production of collagen in the skin.
-
FDA approves long acting facial filler
New, effective peel in market
FDA approval for EVOLENCE
Anti-wrinkle product SculptraAesthetic approved
Better Body Solutions launches painless alternative to liposuction
